Polypharmacy and Bleeding Outcomes After Percutaneous Coronary Intervention

Effect of polypharmacy on bleeding with rivaroxaban versus vitamin K antagonist for treatment of venous thromboembolism

(2022) Ingrid M. Bistervels et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Gastrointestinal Bleeding During Direct Oral Anticoagulant Therapy in Patients With Nonvalvular Atrial Fibrillation and Risk of Polypharmacy

(2022) Taku Honda et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Effects on Mortality and Major Bleeding of Radial Versus Femoral Artery Access for Coronary Angiography or Percutaneous Coronary Intervention: Meta-Analysis of Individual Patient Data From 7 Multicenter Randomized Clinical Trials

(2022) Giuseppe Gargiulo et al.   CIRCULATION

Comparison of Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting Among Patients with Three-Vessel Coronary Artery Disease in the New-Generation Drug-Eluting Stents Era (From CREDO-Kyoto PCI/CABG Registry Cohort-3)

(2021) Yukiko Matsumura-Nakano et al.   AMERICAN JOURNAL OF CARDIOLOGY

Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graftinge Among Patients with Unprotected Left Main Coronary Artery Disease in the New-Generation Drug-Eluting Stents Era (From the CREDO-Kyoto PCI/CABG Registry Cohort-3)

(2021) Ko Yamamoto et al.   AMERICAN JOURNAL OF CARDIOLOGY

Effect of Polypharmacy on Long-Term Mortality After Percutaneous Coronary Intervention

(2021) Ko Yamamoto et al.   AMERICAN JOURNAL OF CARDIOLOGY

Fall-Risk-Increasing Drugs: A Systematic Review and Meta-Analysis: I. Cardiovascular Drugs

(2018) Max de Vries et al.   Journal of the American Medical Directors Association

Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial

(2016) Jeroen Jaspers Focks et al.   BMJ-British Medical Journal

Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial

(2016) Jeroen Jaspers Focks et al.   BMJ-British Medical Journal

Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial FibrillationCLINICAL PERSPECTIVE

(2015) Jonathan P. Piccini et al.   CIRCULATION

Polypharmacy including falls risk-increasing medications and subsequent falls in community-dwelling middle-aged and older adults

(2014) K. Richardson et al.   AGE AND AGEING

Polypharmacy is Associated with an Increased Risk of Bleeding in Elderly Patients with Venous Thromboembolism

(2014) Waltraud Leiss et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Standardized Bleeding Definitions for Cardiovascular Clinical Trials

(2011) Roxana Mehran et al.   CIRCULATION

Polypharmacy as a risk for fall occurrence in geriatric outpatients

(2011) Taro Kojima et al.   Geriatrics & Gerontology International

Incidence of Adverse Drug Events and Medication Errors in Japan: the JADE Study

(2010) Takeshi Morimoto et al.   JOURNAL OF GENERAL INTERNAL MEDICINE